US Supreme Court wraps up health reform after lively arguments
This article was originally published in Scrip
Executive Summary
When Congress passed the 2010 law aimed at reforming the US health care system, whose intent was to protect patients, while expanding insurance coverage to more Americans, several provisions came along for the ride, including the measure that created the pathway giving the US FDA the authority to approve biosimilar medicines, also known as follow-on biologics.